| This is a paid advertisement | Brought to you by Nanobac | View more ads | Email this ad |
 |
||
|
Nanobac Pharmaceuticals Inc. Symbol: OTCBB: NNBP Business Description: The study and development of therapeutic and diagnostic technologies related to the novel pleomorphic pathogen known as nanobacterium sanguineum. Industry: Medical Laboratories & Research Stock Price: $0.065 (Aug. 7) Latest News Jun 07/06 Nanobac Pharmaceuticals Inc. Announces Investor Conference Call, Hosted by John Stanton, Chairman Contact Nanobac Pharmaceuticals Inc.Douglas Mulhall 813-262-9025 dmulhall@nanobaclabs.com or Redwood Consultants LLC 415-884-0348 InvestorInfo@ RedwoodConsultants.com |
About Us Our objective is to develop methods to treat Calcifying Nanoparticles (CNPs), and by so doing find more effective approaches to the diseases associated with them. Pharmaceutical Drug Discovery Our drug discovery and development efforts focus on new and existing compounds that effectively inhibit, destroy or neutralize CNPs. We are narrowly focused on new combinations of well-known drugs that have been shown to eradicate CNPs. Our business strategy is to develop and license compounds to address unmet needs of patients in the cardiovascular and urological disease markets. Diagnostics Our diagnostics division develops in vitro diagnostic products and laboratory services that are used worldwide.
|
|